 Tzu Phang
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 4 | 2017 | 147 | 0.450 |
Why?
| | Gene Expression Profiling | 15 | 2014 | 1706 | 0.440 |
Why?
| | Software | 5 | 2013 | 608 | 0.440 |
Why?
| | Databases, Genetic | 3 | 2009 | 232 | 0.380 |
Why?
| | Gene Expression Regulation | 9 | 2017 | 2548 | 0.370 |
Why?
| | Mammary Glands, Animal | 3 | 2006 | 124 | 0.300 |
Why?
| | Chorionic Gonadotropin | 5 | 2000 | 80 | 0.300 |
Why?
| | Alternative Splicing | 1 | 2009 | 218 | 0.280 |
Why?
| | Receptors, LH | 4 | 2000 | 9 | 0.280 |
Why?
| | Nuclear Proteins | 3 | 2017 | 663 | 0.260 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2017 | 67 | 0.250 |
Why?
| | Oligonucleotide Array Sequence Analysis | 12 | 2014 | 769 | 0.250 |
Why?
| | Face | 3 | 2017 | 165 | 0.220 |
Why?
| | Computational Biology | 4 | 2013 | 599 | 0.220 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 77 | 0.190 |
Why?
| | Dog Diseases | 2 | 2012 | 52 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 259 | 0.170 |
Why?
| | Precancerous Conditions | 1 | 2021 | 163 | 0.170 |
Why?
| | Hemangiosarcoma | 2 | 2010 | 20 | 0.170 |
Why?
| | Precision Medicine | 1 | 2024 | 387 | 0.170 |
Why?
| | Hermanski-Pudlak Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 63 | 0.160 |
Why?
| | Respiratory System | 2 | 2017 | 154 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 821 | 0.150 |
Why?
| | Database Management Systems | 2 | 2009 | 48 | 0.150 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 400 | 0.150 |
Why?
| | Systems Biology | 2 | 2017 | 59 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2012 | 1356 | 0.140 |
Why?
| | Phospholipase C delta | 1 | 2017 | 4 | 0.140 |
Why?
| | Proteins | 3 | 2000 | 942 | 0.140 |
Why?
| | Maxillofacial Development | 1 | 2017 | 15 | 0.140 |
Why?
| | Airway Remodeling | 1 | 2017 | 61 | 0.140 |
Why?
| | Ectoderm | 1 | 2017 | 50 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2017 | 157 | 0.130 |
Why?
| | Cluster Analysis | 4 | 2010 | 482 | 0.130 |
Why?
| | Mesoderm | 1 | 2017 | 137 | 0.130 |
Why?
| | Photoaffinity Labels | 3 | 2000 | 6 | 0.130 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 81 | 0.120 |
Why?
| | DNA Copy Number Variations | 2 | 2021 | 170 | 0.120 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.120 |
Why?
| | Proline Oxidase | 1 | 2015 | 6 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 386 | 0.120 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 330 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2017 | 132 | 0.120 |
Why?
| | Gene Expression | 3 | 2016 | 1472 | 0.120 |
Why?
| | Response Elements | 1 | 2015 | 90 | 0.120 |
Why?
| | Dogs | 3 | 2012 | 381 | 0.120 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2014 | 27 | 0.120 |
Why?
| | Transcription Factor AP-2 | 1 | 2014 | 83 | 0.110 |
Why?
| | Cleft Lip | 1 | 2014 | 43 | 0.110 |
Why?
| | Lung Neoplasms | 2 | 2021 | 2344 | 0.110 |
Why?
| | Internet | 2 | 2009 | 616 | 0.110 |
Why?
| | Gene Dosage | 1 | 2014 | 143 | 0.110 |
Why?
| | Cleft Palate | 1 | 2014 | 57 | 0.110 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1443 | 0.110 |
Why?
| | Lactation | 2 | 2006 | 170 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2015 | 1418 | 0.110 |
Why?
| | Gene Regulatory Networks | 3 | 2013 | 284 | 0.100 |
Why?
| | Cell Line | 6 | 2016 | 2781 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2019 | 1119 | 0.100 |
Why?
| | Introns | 1 | 2014 | 251 | 0.100 |
Why?
| | Antiporters | 2 | 2003 | 22 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2016 | 1065 | 0.100 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 23 | 0.100 |
Why?
| | NF-kappa B | 2 | 2014 | 653 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 480 | 0.100 |
Why?
| | Mice | 12 | 2021 | 16937 | 0.100 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2012 | 11 | 0.100 |
Why?
| | Iodine Radioisotopes | 5 | 2000 | 143 | 0.100 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 105 | 0.090 |
Why?
| | Animals | 17 | 2021 | 35360 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 958 | 0.090 |
Why?
| | Transcriptome | 2 | 2017 | 887 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 442 | 0.090 |
Why?
| | Immunity, Innate | 3 | 2012 | 804 | 0.090 |
Why?
| | Databases, Nucleic Acid | 1 | 2010 | 33 | 0.090 |
Why?
| | Genomics | 2 | 2024 | 716 | 0.090 |
Why?
| | Comparative Genomic Hybridization | 1 | 2010 | 32 | 0.090 |
Why?
| | Philadelphia Chromosome | 1 | 2010 | 18 | 0.090 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 146 | 0.090 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 69 | 0.080 |
Why?
| | Down-Regulation | 2 | 2010 | 636 | 0.080 |
Why?
| | Influenza A virus | 1 | 2011 | 100 | 0.080 |
Why?
| | NFATC Transcription Factors | 1 | 2010 | 84 | 0.080 |
Why?
| | Adenoma | 1 | 2012 | 214 | 0.080 |
Why?
| | Reoviridae | 1 | 2010 | 37 | 0.080 |
Why?
| | Dexamethasone | 3 | 2017 | 346 | 0.080 |
Why?
| | Encephalitis, Viral | 1 | 2010 | 43 | 0.080 |
Why?
| | Humans | 28 | 2024 | 129622 | 0.080 |
Why?
| | Reoviridae Infections | 1 | 2010 | 54 | 0.080 |
Why?
| | Wnt Proteins | 1 | 2010 | 127 | 0.080 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 118 | 0.080 |
Why?
| | Alcohol-Related Disorders | 1 | 2010 | 118 | 0.080 |
Why?
| | Breeding | 1 | 2009 | 62 | 0.080 |
Why?
| | Algorithms | 2 | 2009 | 1622 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 297 | 0.080 |
Why?
| | Biomarkers, Tumor | 2 | 2012 | 1181 | 0.070 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 133 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 779 | 0.070 |
Why?
| | RNA Polymerase II | 3 | 2017 | 317 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2010 | 389 | 0.070 |
Why?
| | Data Collection | 1 | 2010 | 650 | 0.070 |
Why?
| | Blood Platelets | 1 | 2010 | 380 | 0.070 |
Why?
| | Sleep | 1 | 2013 | 685 | 0.070 |
Why?
| | Pregnenolone Carbonitrile | 1 | 2006 | 2 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2003 | 835 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2832 | 0.070 |
Why?
| | Models, Statistical | 1 | 2010 | 623 | 0.070 |
Why?
| | Receptors, Steroid | 1 | 2006 | 49 | 0.070 |
Why?
| | Up-Regulation | 2 | 2006 | 840 | 0.060 |
Why?
| | Influenza, Human | 1 | 2012 | 601 | 0.060 |
Why?
| | Inflammation | 2 | 2014 | 2736 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2008 | 582 | 0.060 |
Why?
| | Neoadjuvant Therapy | 1 | 2008 | 383 | 0.060 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2016 | 11 | 0.060 |
Why?
| | RNA, Messenger | 6 | 2010 | 2708 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 385 | 0.060 |
Why?
| | Lung | 2 | 2010 | 3931 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 532 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1480 | 0.060 |
Why?
| | Mutagenesis | 3 | 2002 | 181 | 0.060 |
Why?
| | Alcoholism | 1 | 2010 | 766 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5440 | 0.060 |
Why?
| | Calcium | 1 | 2010 | 1213 | 0.060 |
Why?
| | Models, Biological | 3 | 2012 | 1722 | 0.050 |
Why?
| | Transcription Factors | 2 | 2009 | 1651 | 0.050 |
Why?
| | Protein Binding | 3 | 2016 | 2121 | 0.050 |
Why?
| | Signal Transduction | 6 | 2015 | 4925 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2006 | 497 | 0.050 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 14 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 98 | 0.050 |
Why?
| | Pregnancy, Animal | 1 | 2003 | 53 | 0.050 |
Why?
| | Cells, Cultured | 4 | 2017 | 4083 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 429 | 0.050 |
Why?
| | Cell Membrane | 2 | 2006 | 732 | 0.050 |
Why?
| | Tetracycline Resistance | 1 | 2002 | 5 | 0.050 |
Why?
| | Female | 14 | 2021 | 68770 | 0.050 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2003 | 51 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2022 | 53 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 877 | 0.050 |
Why?
| | Binding Sites | 4 | 2015 | 1252 | 0.050 |
Why?
| | Laser Capture Microdissection | 1 | 2021 | 24 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 422 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 107 | 0.050 |
Why?
| | Amino Acid Sequence | 3 | 2003 | 2058 | 0.050 |
Why?
| | Brain | 2 | 2013 | 2679 | 0.050 |
Why?
| | Liver | 2 | 2006 | 1839 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 3717 | 0.050 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2022 | 200 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 130 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 2142 | 0.040 |
Why?
| | Blotting, Western | 2 | 2016 | 1205 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2022 | 362 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 487 | 0.040 |
Why?
| | Chemokines | 2 | 2012 | 226 | 0.040 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 70 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 594 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2016 | 1198 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2019 | 32 | 0.040 |
Why?
| | Breast Neoplasms | 2 | 2009 | 2142 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 833 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1038 | 0.040 |
Why?
| | Apoptosis | 3 | 2014 | 2503 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4063 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2015 | 1207 | 0.040 |
Why?
| | Haplotypes | 1 | 2019 | 475 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 317 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 205 | 0.030 |
Why?
| | Jaw | 1 | 2017 | 24 | 0.030 |
Why?
| | Hypertrophy | 1 | 2017 | 121 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2017 | 128 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2017 | 160 | 0.030 |
Why?
| | Pregnancy | 3 | 2006 | 6402 | 0.030 |
Why?
| | Nose | 1 | 2017 | 63 | 0.030 |
Why?
| | Tongue | 1 | 2017 | 75 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2017 | 267 | 0.030 |
Why?
| | Adenoviridae | 1 | 2017 | 192 | 0.030 |
Why?
| | Acetic Acid | 1 | 1996 | 16 | 0.030 |
Why?
| | Autoradiography | 1 | 1996 | 73 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1996 | 109 | 0.030 |
Why?
| | Hypoxia | 1 | 2003 | 1084 | 0.030 |
Why?
| | Acetates | 1 | 1996 | 100 | 0.030 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 83 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2014 | 2391 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 457 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 643 | 0.030 |
Why?
| | Exons | 2 | 2010 | 342 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 448 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2014 | 295 | 0.030 |
Why?
| | Prognosis | 2 | 2012 | 3794 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2003 | 1171 | 0.030 |
Why?
| | Bronchi | 1 | 2015 | 247 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 891 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4420 | 0.030 |
Why?
| | Enkephalins | 1 | 2013 | 16 | 0.030 |
Why?
| | Education | 1 | 2013 | 101 | 0.030 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.030 |
Why?
| | Cartilage | 1 | 2014 | 180 | 0.030 |
Why?
| | Prealbumin | 1 | 2013 | 28 | 0.030 |
Why?
| | Cytokines | 2 | 2012 | 2017 | 0.030 |
Why?
| | Male | 8 | 2013 | 63674 | 0.030 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 88 | 0.020 |
Why?
| | Myosins | 1 | 2013 | 133 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2010 | 3215 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 406 | 0.020 |
Why?
| | Protein Precursors | 1 | 2013 | 127 | 0.020 |
Why?
| | Models, Molecular | 3 | 2003 | 1492 | 0.020 |
Why?
| | Lectins, C-Type | 1 | 2012 | 71 | 0.020 |
Why?
| | Protein Structure, Secondary | 2 | 2003 | 341 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2014 | 366 | 0.020 |
Why?
| | Exome | 1 | 2013 | 220 | 0.020 |
Why?
| | Bone and Bones | 1 | 2014 | 299 | 0.020 |
Why?
| | DNA Mutational Analysis | 2 | 2003 | 387 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 845 | 0.020 |
Why?
| | Middle Aged | 5 | 2012 | 31150 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2016 | 575 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 311 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 331 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 648 | 0.020 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 15 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2010 | 20 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2010 | 92 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 317 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2010 | 87 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2010 | 76 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 485 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2011 | 84 | 0.020 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.020 |
Why?
| | Dasatinib | 1 | 2010 | 54 | 0.020 |
Why?
| | Phagocytosis | 1 | 2012 | 362 | 0.020 |
Why?
| | Markov Chains | 1 | 2010 | 117 | 0.020 |
Why?
| | Fibroblasts | 1 | 2015 | 948 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 189 | 0.020 |
Why?
| | Amino Acid Motifs | 2 | 2000 | 213 | 0.020 |
Why?
| | Thiazoles | 1 | 2010 | 117 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 640 | 0.020 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 33 | 0.020 |
Why?
| | ras Proteins | 1 | 2010 | 144 | 0.020 |
Why?
| | Demography | 1 | 2010 | 279 | 0.020 |
Why?
| | Benzamides | 1 | 2010 | 207 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1839 | 0.020 |
Why?
| | Quality Control | 1 | 2009 | 163 | 0.020 |
Why?
| | Amino Acid Substitution | 2 | 2000 | 282 | 0.020 |
Why?
| | Inheritance Patterns | 1 | 2009 | 46 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2006 | 2406 | 0.020 |
Why?
| | Cyclosporine | 1 | 2010 | 263 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 296 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2009 | 226 | 0.020 |
Why?
| | RNA Splicing | 1 | 2010 | 262 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 70 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2011 | 359 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2008 | 200 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 940 | 0.020 |
Why?
| | Interferons | 1 | 2010 | 194 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1642 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| | Estrogen Receptor Modulators | 1 | 2008 | 17 | 0.020 |
Why?
| | Ethanol | 1 | 2013 | 589 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 452 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1295 | 0.020 |
Why?
| | S100 Proteins | 1 | 2008 | 36 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 610 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 587 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 644 | 0.020 |
Why?
| | Cell Communication | 1 | 2009 | 301 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 342 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 638 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 335 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 916 | 0.020 |
Why?
| | Tamoxifen | 1 | 2008 | 200 | 0.020 |
Why?
| | Adult | 4 | 2012 | 35572 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 592 | 0.020 |
Why?
| | Pyrimidines | 1 | 2010 | 459 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1156 | 0.020 |
Why?
| | Time Factors | 2 | 2009 | 6556 | 0.020 |
Why?
| | Phenotype | 1 | 2014 | 3076 | 0.020 |
Why?
| | Rats | 2 | 2006 | 5499 | 0.020 |
Why?
| | Chromatin | 1 | 2009 | 479 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1333 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2008 | 332 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2009 | 504 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 149 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 853 | 0.020 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 355 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 426 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 14519 | 0.010 |
Why?
| | Dietary Fats | 1 | 2006 | 301 | 0.010 |
Why?
| | Research Design | 1 | 2011 | 1043 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2008 | 743 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1698 | 0.010 |
Why?
| | Sequence Analysis, Protein | 1 | 2003 | 28 | 0.010 |
Why?
| | Milk Proteins | 1 | 2003 | 33 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1501 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2011 | 1902 | 0.010 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2008 | 759 | 0.010 |
Why?
| | Osteopontin | 1 | 2003 | 31 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 107 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 2002 | 12 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2003 | 155 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 66 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 45 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 87 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5420 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2635 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3083 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 154 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1565 | 0.010 |
Why?
| | Plasmids | 1 | 2002 | 358 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2119 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2002 | 548 | 0.010 |
Why?
| | Cysteine | 1 | 2002 | 195 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 840 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2282 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2000 | 227 | 0.010 |
Why?
| | Serine | 1 | 2000 | 138 | 0.010 |
Why?
| | Tyrosine | 1 | 2000 | 223 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2000 | 237 | 0.010 |
Why?
| | Lipids | 1 | 2003 | 625 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 7084 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 379 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 774 | 0.010 |
Why?
| | Aged | 2 | 2011 | 22099 | 0.010 |
Why?
| | Protein Conformation | 1 | 2000 | 859 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2003 | 1096 | 0.010 |
Why?
| | Antibodies | 1 | 1998 | 398 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 12426 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2003 | 1894 | 0.010 |
Why?
| | Adolescent | 1 | 2003 | 20391 | 0.000 |
Why?
| | Child | 1 | 2003 | 20882 | 0.000 |
Why?
|
|
Phang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|